0001209191-19-022065.txt : 20190401
0001209191-19-022065.hdr.sgml : 20190401
20190401184509
ACCESSION NUMBER: 0001209191-19-022065
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190323
FILED AS OF DATE: 20190401
DATE AS OF CHANGE: 20190401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Steinkrauss William
CENTRAL INDEX KEY: 0001772403
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30347
FILM NUMBER: 19722246
MAIL ADDRESS:
STREET 1: C/O CURIS, INC.,
STREET 2: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CURIS INC
CENTRAL INDEX KEY: 0001108205
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043505116
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-503-6500
MAIL ADDRESS:
STREET 1: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2019-03-23
0
0001108205
CURIS INC
CRIS
0001772403
Steinkrauss William
4 MAGUIRE ROAD
LEXINGTON
MA
02421
0
1
0
1
VP, Finance & Treasurer
Principal Accounting Officer
Common Stock
9767
D
Employee stock option (right to buy)
9.60
2026-09-11
Common Stock
16000
D
Employee stock option (right to buy)
12.05
2027-03-01
Common Stock
11220
D
Employee stock option (right to buy)
3.45
2028-01-21
Common Stock
15400
D
Employee stock option (right to buy)
1.16
2029-01-20
Common Stock
115000
D
This option vests as to 25% of the original 16,000 shares underlying the award on August 29, 2017 and as to an additional 6.25% of the original shares underlying the award on each successive three month period thereafter, subject to continued service.
This option vests as to 25% of the original 11,220 shares underlying the award on January 1, 2018 and as to an additional 6.25% of the original shares underlying the award on each successive three month period thereafter, subject to continued service.
This option vests as to 25% of the original 15,400 shares underlying the award on the first anniversary of the date of grant and as to an additional 6.25% of the original shares underlying the award on each successive three month period thereafter, subject to continued service.
This option vests as to 25% of the original 115,000 shares underlying the award on the first anniversary of the date of grant and as to an additional 6.25% of the original shares underlying the award on each successive three month period thereafter, subject to continued service.
/s/ Robert Pratt, attorney-in-fact
2019-04-01
EX-24.3_845114
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
The undersigned, as a Section 16 reporting person of Curis, Inc., hereby
constitutes and appoints each of James Dentzer, Robert Pratt, Nancy Soohoo,
William Steinkrauss and Wilmer Cutler Pickering Hale and Dorr LLP, as outside
counsel to the Company, and each of them individually, as his or her true and
lawful attorney in fact and agent with full power of substitution, for him or
her in any and all capacities to:
(1) Execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or director of the "Company", Forms 3, 4, and 5 in accordance
with Section 16(a) of the Securities Exchange Act of 1934 (the "Exchange Act")
and the rules thereunder, or any successor laws and regulations promulgated
thereunder;
(2) Perform any and all acts for and on behalf of the undersigned which may be
necessary or appropriate to complete and execute any such Form 3, 4, or 5,
complete and execute any amendment or amendments thereto, and timely file such
form with the United States Securities and Exchange Commission and any stock
exchange or similar authority; and
(3) Take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney in fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney in fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney in fact may approve in such
attorney in fact's discretion.
The undersigned hereby grants to each such attorney in fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney in fact, or such attorney
in fact's substitute or substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and powers herein granted. The
undersigned acknowledges that the foregoing attorneys in fact, in serving in
such capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys in fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 28th day of March 2019.
/s/ William Steinkrauss
-----------------------
Signature
William Steinkrauss